Mortimer JE, Bading JR, Frankel PH, Caroll M, et al. Use of (64)Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine (T-DM1) for Metastatic Breast Cancer: A Pilot Study. J Nucl Med 2021 Dec 2. pii: jnumed.121.262940. doi: 10.2967/jnumed.121.262940.
PMID: 34857660